ELISE VAN GORDEN: Open Payments
NPI 1356018436 · OXFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 33 payments from 9 companies in 2025. Trend: 2023 $69 · 2024 $62 · 2025 $1,180
Food & beverage: $1,180
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $478 |
| Axsome Therapeutics, Inc. | 4 | $184 |
| Neurocrine BioSciences, Inc. | 2 | $136 |
| E.R. Squibb & Sons, L.L.C. | 3 | $112 |
| UCB, Inc. | 2 | $87 |
| Teva Pharmaceuticals USA, Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
| Lundbeck LLC | 1 | $18 |
Products named: LYBALVI, ARISTADA, Auvelity, INGREZZA, COBENFY, Nayzilam, UZEDY, REXULTI.
Industry payments across NY — which companies pay providers there.
